Insulin induces tyrosine dephosphorylation of a 92 kDA protein in suspended monocytes

G Zoppini1, P Galante, M Zardini

  • 1Divisione di Endocrinologia e Malattie del Metabolismo, Università di Verona, Italy.

Insights

Insulin triggers dephosphorylation of a 92 kDa protein in suspended monocytes, suggesting activation of a tyrosine phosphatase. This occurs without phosphorylating Insulin Receptor Substrate-1 (IRS-1), revealing a unique insulin signaling pathway in these immune cells.

Area of Science:

  • Immunology
  • Cellular Biology
  • Endocrinology

Background:

  • Monocytes possess insulin receptors, but their insulin response is not well understood.
  • Cell adhesion can alter cellular responses to hormones like insulin.
  • Investigating insulin's effects on monocytes is crucial for understanding immune cell function and metabolic regulation.

Purpose of the Study:

  • To characterize insulin-induced tyrosine phosphorylation patterns in monocytes.
  • To investigate how insulin affects protein phosphorylation in suspended monocytes.
  • To determine if insulin signaling in monocytes involves Insulin Receptor Substrate-1 (IRS-1).

Main Methods:

  • Monocytes were isolated using sequential gradient centrifugation.
  • Tyrosine phosphoproteins were analyzed via immunoblotting using antiphosphotyrosine antibodies.
  • Insulin's effect on protein phosphorylation was assessed in a dose- and time-dependent manner.

Main Results:

  • Insulin induced a dose- and time-dependent dephosphorylation of a ~92 kDa protein in suspended monocytes.
  • Insulin did not stimulate tyrosine phosphorylation of Insulin Receptor Substrate-1 (IRS-1).
  • The findings suggest insulin activates a tyrosine phosphatase in monocytes.

Conclusions:

  • In suspended monocytes, insulin appears to activate a tyrosine phosphatase.
  • This phosphatase dephosphorylates a specific protein (~92 kDa).
  • Insulin signaling in monocytes differs from pathways involving IRS-1 phosphorylation.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...